SCHEMBL1542069

SCHEMBL1542069

[CH2]C=CC=CC=C[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1677666 1.00
SCHEMBL43443 0.94
SCHEMBL7924393 0.82
SCHEMBL236557 0.82
SCHEMBL19973748 0.82
SCHEMBL7924391 0.82
SCHEMBL236556 0.82
SCHEMBL19973744 0.82
SCHEMBL19973793 0.78 ALDH1A1 (0.44)
SCHEMBL233994 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4349366-A1 PHARMACEUTICAL COMPOSITION Mie University (JP) 2024-04-10 EP disclosed
US-20240027901-A1 PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION USING SAME SAN-APRO LTD. (JP) 2024-01-25 US disclosed
WO-2024019127-A1 HYALURONIC ACID DERIVATIVE PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION 旭化成株式会社 2024-01-25 WO disclosed
WO-2024019118-A1 HYALURONIC ACID DERIVATIVE DRUG COMPOSITION AND DRUG COMPOSITION 旭化成株式会社 2024-01-25 WO disclosed
WO-2023234376-A1 HYALURONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION 旭化成株式会社 2023-12-07 WO disclosed
EP-4261214-A1 PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION USING SAME San-Apro Ltd. (JP) 2023-10-18 EP disclosed
US-20230085879-A1 HYALURONIC ACID DERIVATIVE COMPOSITION, PHARMACEUTICAL COMPOSITION AND HYALURONIC ACID DERIVATIVE-DRUG CONJUGATE COMPOSITION ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-03-23 US disclosed
US-20230066990-A1 HYALURONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND HYALURONIC ACID DERIVATIVE-DRUG COMPLEX ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-03-02 US disclosed
US-11564971-B2 Hyaluronic acid derivative having amino acid and steryl group introduced thereinto CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-01-31 US disclosed
EP-4101466-A1 HYALURONIC ACID DERIVATIVE COMPOSITION, PHARMACEUTICAL COMPOSITION AND HYALURONIC ACID DERIVATIVE-DRUG CONJUGATE COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2022-12-14 EP disclosed
EP-0570594-B1 HYDROXAMIC ACID DERIVATIVE BASED ON AROMATIC SULFONAMIDE SHIONOGI & CO (JP) 1997-07-30 EP disclosed
US-5643958-A ANTITUMOR BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0776884-A1 SUBSTITUTED AMIDE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-06-04 EP disclosed
US-5616803-A EXHIBIT SQUALENE SYNTHASE-INHIBITORY ACTIVITIES; USEFUL IN TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA, HYPERLIPEMIA AND ARTERIOSCLEROSIS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-04-01 US disclosed
US-5606101-A INTERMEDIATES FOR SQUALENE SYNTHASE INHIBITORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-02-25 US disclosed
WO-1997001275-A1 COMBINATIONS OF INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1997-01-16 WO disclosed
US-5534654-A ANTITUMOR, ANTIINFLAMMATORY, INHIBITOR OF LYMPHOCYTE ADHESIVE FACTORS SHIONOGI & CO., LTD. (JP) 1996-07-09 US disclosed
US-5488149-A SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-01-30 US disclosed
EP-0611749-A1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-08-24 EP disclosed
EP-0570594-A1 HYDROXAMIC ACID DERIVATIVE BASED ON AROMATIC SULFONAMIDE SHIONOGI & CO., LTD. (JP) 1993-11-24 EP disclosed